Enterprise Account Executive, Signos
$150-200k
Glucose monitoring tools for weight loss
Job no longer available
Glucose monitoring tools for weight loss
101-200 employees
Job no longer available
$150-200k
101-200 employees
Company mission
To optimize metabolic health for all.
Role
Who you are
- 10+ years of a demonstrable track record for enterprise & employer sales in the Healthcare/point solution space
- Sales scope including developing, managing & executing on pipelines of $5-$20M
- Experience in shaping & optimizing pricing and risk share programs for employer sponsored programs
- Deep understanding of the interconnectivity between employers, TPA’s & payers in the self insured Market, to drive the optimal value for employers / stakeholders
- Ability to work across Marketing & Product functions to reflect Market need back into GTM messaging and future Product roadmap items, for an optimized value story
- Familiarity with the post sale, end to end client lifecycle, in particular optimizing - adoption, adherence & ongoing client account support, to inform Sales positioning
- Ability to think strategically and drive the vision of the Signos Enterprise solution, while also being adept at executing at the ground level
- Desire to have outsized impact on Healthcare Industry at large, and belief in the Mission
What the job involves
- The role of Enterprise GTM & Sales Executive is a critical component as Signos builds on an established portfolio of clients & proof points, to expand its reach within the large / jumbo ASO Employer & National Consultancy verticals
- The Enterprise GTM & Sales Executive is a multi-dimensional role that influences & drives overall Company strategy and Sales execution of the Signos Enterprise Solution for Businesses & Healthcare stakeholders
- This role will leverage already established proof points across an existing client base, to refine the go-forward GTM in the Large & Jumbo Markets for ASO Employers
- This role will require an Executive with established credibility across key employer stakeholder / buyers in the Healthcare space, as well as the ability to help lead all stages of a rapidly evolving client lifecycle
- Direct focus & targeting of ICPs within the Large and Jumbo employer Markets
- Refine value proposition & positioning for target employer audiences
- Evolve existing pricing & packaging of product sets to drive enhanced conversion
- Assist in generating & refining Sales collateral (along with Marketing), as the business adjusts to changing Market dynamics and the unique needs within each target employer vertical
- Close collaboration with Product & Marketing to drive innovation within the core offering to meet Market need
- Assist in further developing ROI & risk share models based on existing clinical and real world deployment outcomes, enhancing the core value proposition
- Leverage existing Marketing tools & personal network to drive awareness & demand
- Refine overall Funnel management across target employer verticals
- Assist Finance in evolving forecast models and KPIs
- Execute on a refined GTM playbook and pitch methodology to drive conversion
- Assist Operations in further refining Sales execution including; contract execution & tracking, invoicing, and payment confirmation
Application process
- Applications accepted through November 30, 2025
Our take
Sticking to diets and exercise regimes is tough - we all make that New Year’s resolution, but less than a third of us actually follow through. Signos sets out to make it easier with its real-time glucose monitoring to help you see how food, exercise and more is affecting your body.
What’s unique about its package is the CGM (Continuous Glucose Monitor) - the first FDA approved of its kind - a small wearable patch to put on your arm, which connects to an app that displays your glucose levels at all times. Input what you’re eating into the platform, and it starts to build a picture of how different foods affect you personally.
Signos is really setting itself apart now as its system has been approved by the US Food and Drug Administration for weight management, giving it far more credibility than just being another health-tech startup. Unlike expensive GLP-1 drugs from companies like Novo Nordisk and Eli Lilly, which can cost around $1,000 a month and aren't always easy to access, Signos is available directly to consumers and at a lower price point. With many Americans struggling with their weight, it's positioning itself in an accessible, long-term tool rather than a quick fix.
Freddie
Company Specialist at Welcome to the Jungle
Company
Funding (2 rounds)
Oct 2023
$20m
SERIES B
Nov 2021
$13m
SERIES A
Total funding: $33m
Company HQ
Mills Estates, Burlingame, CA
Leadership
Sharam Fouladgar-Mercer
(Co-Founder & CEO)A former associate at JP Morgan, they have sat on the board of Makara and TouchCommerce. They are still a board member at Onclusive - which they founded and are the former CEO of - as well holding advisory roles at Correlation Ventures and Clearco.
Pierre Wehbe
(Co-Founder & Chief Architect)Previously co-founded European Innovation Academy and Sfearia, as well as working as a Software Engineer at Atheer.
Bill Tancer
(Co-Founder & Chief Data Officer)Previously worked as a Prosecuting Attorney within the US Navy Reserves, as Director of Market Research at LookSmart, Director of Corporate Strategy at Zaplet, SVP of Global Research at Experian and Principal at Tancer Advisory Services. They've also published two books about business, one a NYT Bestseller, and still work as an Advisor at Onclusive.
Share this job